View Clinical Trial (Medical Research Study)
Clinical Testing of a Decision Support System for Tobacco Use Treatment
| City: |
|
Burlington |
| State: |
|
Vermont |
| Zip Code: |
|
05405 |
| Conditions: |
|
Bladder Cancer - Cervical Cancer - Esophageal Cancer - Gastric Cancer - Head and Neck Cancer - Kidney Cancer - Leukemia - Liver Cancer - Lung Cancer - Pancreatic Cancer - Tobacco Use Disorder |
| Purpose: |
|
RATIONALE: A computer-assisted stop-smoking program may help doctors counsel patients who
smoke and may help increase the number of patients who stop smoking.
PURPOSE: This phase II trial is studying how well a computer-assisted stop-smoking program
works in helping doctors counsel patients who smoke cigarettes.
|
| Study Summary: |
|
OBJECTIVES:
- Test the hypothesis that the clinical decision support system will improve the rate at
which physicians assist their patients with smoking cessation by providing information
and recommendations on smoking cessation resources.
- Assess whether exposure to information and recommendations facilitated by the smoking
cessation-personal digital assistant (SC-PDA) will increase the rate at which patients
make at least 1 attempt to quit smoking in the month following the physician visit.
- Assess whether exposure to information and recommendations facilitated by the SC-PDA
will increase the reported use of counseling and pharmacotherapy during those attempts
over that observed with a smoking status identification system alone.
- Evaluate the acceptance of the SC-PDA into the workflow of ambulatory care clinics.
OUTLINE: In weeks 1-12, physicians have access to a smoking status identification system
(SSID) that reminds the physician the smoking status of the patient they are evaluating. In
weeks 6-12, physicians have access to a computerized smoking cessation clinical decision
support system using a hand-held personal digital assistant (SC-PDA) that they can use in
the exam room with their patients who smoke. The SC-PDA system assists physicians in
recommending and prescribing approved pharmacotherapy; facilitates referral of patients to
local counseling resources; prints a tailored handout for a patient listing specific
recommendations, instructions, and cessation resources; and generates the necessary
documentation to support billing for this intervention.
Patients who visit their physician in weeks 2-6 or weeks 8-12 complete a survey after their
clinic visit and undergo a telephone interview 1 month later. Physicians undergo interviews
and focus groups are conducted with clinic staff in weeks 12-16.
|
| Criteria: |
|
DISEASE CHARACTERISTICS:
- Current smoker, defined as self-reported smoking most days or every day (patient)
- Seeks care at a participating Fletcher Allen Health Care primary care clinic
(patient)
PATIENT CHARACTERISTICS:
- Not specified
PRIOR CONCURRENT THERAPY:
- Not specified
|
| NCT ID: |
|
NCT00865553 |
| Primary Contact: |
|
Principal Investigator
Theodore W. Marcy, MD, MPH
University of Vermont
|
| Backup Contact: |
|
N/A |
| Location Contact: |
|
Burlington, Vermont 05405
United States
Clinical Trials Office - Vermont Cancer Center at University o
Phone: 802-656-2178
Site Status: Recruiting |
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
May 23, 2013 |
| Modifications to this listing: |
|
Only selected fields are shown, please use the link
below to view all information about this clinical trial. |
|
Click to view Full Listing
|